Aptevo Therapeutics (APVO) Inventory Average (2016 - 2019)
Aptevo Therapeutics (APVO) posted Inventory Average of $6.8 million for Q4 2019, down 5.73% sequentially from $7.2 million in Q3 2019, and up 136.72% YoY from $2.9 million in Q4 2018.
Aptevo Therapeutics (APVO) Inventory Average (2016 - 2019) Analysis & Trends
Aptevo Therapeutics has reported Inventory Average for 4 years, with the latest figure at $6.8 million in Q4 2019.
- Quarterly Inventory Average rose 136.72% year-over-year to $6.8 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $6.8 million (up 136.72% YoY) and the FY2019 annual result came in at $4.0 million, up 66.65% from the prior year.
- Inventory Average eased to $6.8 million in Q4 2019 per APVO's latest filing, from $7.2 million in the prior quarter.
- Over five years, Inventory Average peaked at $15.9 million in Q3 2016 and troughed at $1.1 million in Q4 2017.
- A 4-year average of $5.2 million and a median of $4.4 million in 2017 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2017 and 2019: Inventory Average plunged 81.18% in 2017, then jumped 165.88% in 2019.
- Over 4 years, Inventory Average stood at $6.0 million in 2016, then slumped by 81.18% to $1.1 million in 2017, then surged by 154.04% to $2.9 million in 2018, then soared by 136.72% to $6.8 million in 2019.
- According to Business Quant data, Inventory Average over the past three periods registered $6.8 million, $7.2 million, and $5.7 million for Q4 2019, Q3 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 6.81 Mn |
| Sep 30, 2019 | 7.22 Mn |
| Jun 30, 2019 | 5.66 Mn |
| Mar 31, 2019 | 3.07 Mn |
| Dec 31, 2018 | 2.88 Mn |
| Sep 30, 2018 | 3.47 Mn |
| Jun 30, 2018 | 2.13 Mn |
| Mar 31, 2018 | 1.16 Mn |
| Dec 31, 2017 | 1.13 Mn |
| Sep 30, 2017 | 4.61 Mn |
| Jun 30, 2017 | 8.02 Mn |
| Mar 31, 2017 | 4.26 Mn |
| Dec 31, 2016 | 6.02 Mn |
| Sep 30, 2016 | 15.85 Mn |